2008
DOI: 10.1016/j.medmal.2008.01.011
|View full text |Cite
|
Sign up to set email alerts
|

Le nouvel âge de la primaquine contre le paludisme

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 49 publications
0
2
0
Order By: Relevance
“…The treatment for proven attacks is based on chloroquine (25 mg/kg for three days). The treatment against dormant stages in the liver consists of a radical cure with primaquine (0.5 mg/kg/d for 14 days) in patients without G6PD deficiency [ 17 , 18 ]. Failures of primaquine are unusual, mostly due to poor observance or inadequate dosage [ 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…The treatment for proven attacks is based on chloroquine (25 mg/kg for three days). The treatment against dormant stages in the liver consists of a radical cure with primaquine (0.5 mg/kg/d for 14 days) in patients without G6PD deficiency [ 17 , 18 ]. Failures of primaquine are unusual, mostly due to poor observance or inadequate dosage [ 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…We encapsulated the weakly basic quinine drug chloroquine using the AS gradient into PFSUVs achieving an EE of 95.4%. Further development of this delivery system encapsulated with chloroquine and other quinine‐based drugs such as primaquine could be highly beneficial for liver‐stage malaria treatment . Another liver‐related infectious disease related to liver impairment is viral hepatitis (hepatitis B and hepatitis C) resulting in liver cirrhosis and hepatocellular carcinoma .…”
Section: Resultsmentioning
confidence: 99%